- Government of Botswana announces new public-private partnership to treat children with cancer and blood disorders
- The $100 million initiative to create a pediatric hematology-oncology treatment network and care infrastructure is supported by $50 million donation from the Bristol-Myers Squibb Foundation and matched by $50 million in additional philanthropy
- Partnership includes Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children’s Hospital and the Governments of Botswana, Uganda and Malawi
By Evan Lee, MD, Vice President, Global Health, Eli Lilly and Company
Working in global development, it’s impossible to avoid seeing the heavy personal and societal tolls being wrought by cancer, chronic respiratory disease, diabetes, heart disease, and mental health. These noncommunicable diseases (NCDs) account for three out of every five deaths across the world. The impact is even greater in developing countries, where limited resources and structural barriers hamper access to care.
There is, however, reason to be hopeful. Public health campaigns, supported by commitments through the U.N. Sustainable Developments Goals, are mounting a global response to address these diseases. And much has already been learned about how to tackle the multi-faceted barriers to health care access through collective and coordinated action. As we look to make widespread impact against NCDs, three lessons emerge that should guide our work.
Developing countries are facing a new challenge from an increase in non- communicable diseases (NCDs) such as cardiovascular disease, cancer, mental illness, diabetes and chronic respiratory disorders. At the same time, while substantial gains have been made in the battle against infectious diseases and child and maternal mortality, these remain a major concern, resulting in a double burden of disease.
Produced by The Economist Intelligence Unit, this report is based on extensive data analysis and desk research, complemented by five in-depth interviews with experts on NCDs.
Download the full report.
By Dave Ricks
Medical science in recent decades has made extraordinary progress in the fight against many diseases. Unfortunately, far too many people do not benefit from all of this progress, especially those living in some low- and middle-income communities. The World Health Organization reports that 400 million people worldwide do not have access to essential health services.[i] Access Accelerated–a new multi-stakeholder partnership announced this week—aims to confront that dismal statistic.